Remifentanil Hydrochloride 00143-9393
Product NDC
00143-9393- Manufacturer
- Hikma Pharmaceuticals Usa Inc.
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- May 15, 2021
- Listing Expires
- December 31, 2026
- Application
- ANDA210594
Active Ingredients
| Ingredient | Strength |
|---|---|
| Remifentanil Hydrochloride | 5 mg/5mL |
Drug Class
Full Opioid Agonists [MoA]Opioid Agonist [EPC]
Packaging Options(1)
10 VIAL in 1 CARTON (0143-9393-10) / 10 mL in 1 VIAL (0143-9393-01)